KNOTUS CoLtd Financials
| 278650 Stock | KRW 2,005 35.00 1.72% |
KNOTUS |
Understanding current and past KNOTUS CoLtd Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of KNOTUS CoLtd's financial statements are interrelated, with each one affecting the others. For example, an increase in KNOTUS CoLtd's assets may result in an increase in income on the income statement.
Please note, the presentation of KNOTUS CoLtd's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, KNOTUS CoLtd's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of KNOTUS CoLtd's management manipulating its earnings.
KNOTUS CoLtd Stock Summary
KNOTUS CoLtd competes with Bridge Biotherapeutics, AptaBio Therapeutics, Cytogen, and Genolution. It offers platform technology services, such as cell-enzyme-based screening, xenograft assay, mitogenic effect test, vaccine antigen, antibody titration, cytokine, MRNA expression, trachea relaxation assay, carrageenan, adjuvant induced paw edema, antipyretic, anti-pain test, isolated blood vessel screening, fibrin plate lysis screening, ferric chloride induced model, food diet induced model, gastric acid secretion, emesis model, MIC test, post antibody effect, enzyme assay, systemic, local infection model, PK study, chemical, transgenic animal, osteoblast-like cell line screening, bone formation marker, and biomarker. The company also provides pharmacokinetictoxico study, toxicology study, and biological drug and toxicclinical pathology services. KNOTUS is traded on Korean Securities Dealers Automated Quotations in South Korea.| Instrument | Korea Stock View All |
| Exchange | KOSDAQ |
| ISIN | KR7278650007 |
| Business Address | 360-1, Sano-dong, Guri, |
| Sector | Healthcare |
| Industry | Biotechnology & Medical Research |
| Benchmark | Dow Jones Industrial |
| Website | www.knotus.co.kr |
| Phone | 82 3 1572 8899 |
| Currency | KRW - South Korean Won |
You should never invest in KNOTUS CoLtd without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of KNOTUS Stock, because this is throwing your money away. Analyzing the key information contained in KNOTUS CoLtd's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
KNOTUS CoLtd Key Financial Ratios
KNOTUS CoLtd's financial ratios allow both analysts and investors to convert raw data from KNOTUS CoLtd's financial statements into concise, actionable information that can be used to evaluate the performance of KNOTUS CoLtd over time and compare it to other companies across industries.KNOTUS Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining KNOTUS CoLtd's current stock value. Our valuation model uses many indicators to compare KNOTUS CoLtd value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across KNOTUS CoLtd competition to find correlations between indicators driving KNOTUS CoLtd's intrinsic value. More Info.KNOTUS CoLtd is rated third in return on equity category among its peers. It also is rated third in profit margin category among its peers fabricating about 0.02 of Profit Margin per Return On Equity. The ratio of Return On Equity to Profit Margin for KNOTUS CoLtd is roughly 42.29 . Comparative valuation analysis is a catch-all model that can be used if you cannot value KNOTUS CoLtd by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for KNOTUS CoLtd's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.KNOTUS CoLtd Systematic Risk
KNOTUS CoLtd's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. KNOTUS CoLtd volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Beta measures systematic risk based on how returns on KNOTUS CoLtd correlated with the market. If Beta is less than 0 KNOTUS CoLtd generally moves in the opposite direction as compared to the market. If KNOTUS CoLtd Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one KNOTUS CoLtd is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of KNOTUS CoLtd is generally in the same direction as the market. If Beta > 1 KNOTUS CoLtd moves generally in the same direction as, but more than the movement of the benchmark.
KNOTUS CoLtd December 23, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of KNOTUS CoLtd help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of KNOTUS CoLtd. We use our internally-developed statistical techniques to arrive at the intrinsic value of KNOTUS CoLtd based on widely used predictive technical indicators. In general, we focus on analyzing KNOTUS Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build KNOTUS CoLtd's daily price indicators and compare them against related drivers.
| Information Ratio | (0.09) | |||
| Maximum Drawdown | 22.28 | |||
| Value At Risk | (3.67) | |||
| Potential Upside | 3.45 |
Complementary Tools for KNOTUS Stock analysis
When running KNOTUS CoLtd's price analysis, check to measure KNOTUS CoLtd's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy KNOTUS CoLtd is operating at the current time. Most of KNOTUS CoLtd's value examination focuses on studying past and present price action to predict the probability of KNOTUS CoLtd's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move KNOTUS CoLtd's price. Additionally, you may evaluate how the addition of KNOTUS CoLtd to your portfolios can decrease your overall portfolio volatility.
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |